As the global economy mends, the 2021 growth of Fibromyalgia Treatment will have significant change from previous year. According to our (LP Information) latest study, the global Fibromyalgia Treatment market size is USD million in 2022 from USD 2800.1 million in 2021, with a change of % between 2021 and 2022. The global Fibromyalgia Treatment market size will reach USD 3175.9 million in 2028, growing at a CAGR of 1.8% over the analysis period.
The United States Fibromyalgia Treatment market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Fibromyalgia Treatment market, reaching US$ million by the year 2028. As for the Europe Fibromyalgia Treatment landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Fibromyalgia Treatment players cover Eli Lilly and Company, Pfizer, Novartis AG, and Allergan, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Fibromyalgia Treatment market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Antidepressants
Anticonvulsants
Muscle Relaxants
Narcotic Analgesics
Non-narcotic Analgesics
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospitals Pharmacies
Clinic Pharmacy
Retail Drug Stores
Online Pharmacies
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Eli Lilly and Company
Pfizer
Novartis AG
Allergan
Aptinyx
Prismic Pharmaceuticals
Innovative Med Concepts
Intec Pharma Ltd.
Astellas Pharma
Savella
Sun Pharmaceutical Industries
Mylan NV
Teva Pharmaceutical Industries
Daiichi Sankyo
Forest Pharmaceuticals
Meiji Seika Pharma
Tonix Pharmaceuticals
Theravance Biopharma